ABVC BioPharma Secures $230K Milestone, Eyes $667M Deal in CNS Botanicals
August 27, 2025 — ABVC BioPharma receives $230K milestone from AiBtl for botanical drugs targeting depression and ADHD, with potential deal value up to $667M in growing CNS markets.